[Effect of phenibut and eglonyl on frequency of tachyarrhythmia paroxysms and central hemodynamics in patients with neurocirculatory dystonia].
D000293:Adolescent; D000328:Adult; D005260:Female; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009449:Neurocirculatory Asthenia / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D013469:Sulpiride / Q000627:therapeutic use*; D013614:Tachycardia, Paroxysmal / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D005680:gamma-Aminobutyric Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use
D005680:gamma-Aminobutyric Acid; D013469:Sulpiride; C008842:4-amino-3-phenylbutyric acid
Vliianie fenibuta i églonila na chastotu paroksizmov takhiaritmii i tsentral'nuiu gemodinamiku u bol'nykh neĭrotsirkuliatornoĭ distonieĭ.